Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of RSV Vaccine,
April 28, 2014 at 16:14 PM EDT
Vaccine candidate was well-tolerated with no vaccine-related serious adverse events Highest immune responses observed with a single ...
